Vertero Therapeutics

Last updated: November 18, 2025
David Donabedian - Cofounder, CEO
David Donabedian - Cofounder, CEO
Country: USA | Funding: $130.9M (+)
Founded: 2016

Website: https://vertero.com/

Vertero Therapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders




Competitors